Recro Pharma, Inc. Insider Trading for May 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Recro Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Recro Pharma, Inc. for May 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 21 2019 | REPH | Recro Pharma, Inc. | Ajdler Arnaud | Director | Buy | P | 9.00 | 40,000 | 360,000 | 1,104,546 | 1.1 M to 1.1 M (+3.76 %) |
| May 15 2019 | REPH | Recro Pharma, Inc. | HENWOOD GERALDINE | President and CEO | Option Exercise | M | 2.47 | 123,500 | 305,045 | 0 | |
| May 15 2019 | REPH | Recro Pharma, Inc. | HENWOOD GERALDINE | President and CEO | Sell | S | 8.89 | 21,306 | 189,381 | 198,141 | 219.4 K to 198.1 K (-9.71 %) |
| May 15 2019 | REPH | Recro Pharma, Inc. | HENWOOD GERALDINE | President and CEO | Sell | S | 8.89 | 123,500 | 1,097,915 | 219,447 | 342.9 K to 219.4 K (-36.01 %) |
| May 15 2019 | REPH | Recro Pharma, Inc. | HENWOOD GERALDINE | President and CEO | Buy | M | 2.47 | 123,500 | 305,045 | 342,947 | 219.4 K to 342.9 K (+56.28 %) |
| May 13 2019 | REPH | Recro Pharma, Inc. | Flynn Karen | Director | Option Exercise | A | 8.80 | 10,888 | 95,814 | 10,888 | |
| May 13 2019 | REPH | Recro Pharma, Inc. | Flynn Karen | Director | Grant | A | 0.00 | 7,955 | 0 | 28,212 | 20.3 K to 28.2 K (+39.27 %) |
| May 10 2019 | REPH | Recro Pharma, Inc. | ALTOMARI ALFRED | Director | Option Exercise | A | 8.80 | 10,888 | 95,814 | 10,888 | |
| May 10 2019 | REPH | Recro Pharma, Inc. | ALTOMARI ALFRED | Director | Grant | A | 0.00 | 7,955 | 0 | 28,912 | 21 K to 28.9 K (+37.96 %) |
| May 10 2019 | REPH | Recro Pharma, Inc. | Ashton William | Director | Option Exercise | A | 8.80 | 10,888 | 95,814 | 10,888 | |
| May 10 2019 | REPH | Recro Pharma, Inc. | Ashton William | Director | Grant | A | 0.00 | 7,955 | 0 | 27,412 | 19.5 K to 27.4 K (+40.89 %) |
| May 10 2019 | REPH | Recro Pharma, Inc. | Reasons Bryan M. | Director | Option Exercise | A | 8.80 | 10,888 | 95,814 | 10,888 | |
| May 10 2019 | REPH | Recro Pharma, Inc. | Reasons Bryan M. | Director | Grant | A | 0.00 | 7,955 | 0 | 22,987 | 15 K to 23 K (+52.92 %) |
| May 10 2019 | REPH | Recro Pharma, Inc. | Berelowitz Michael | Director | Option Exercise | A | 8.80 | 10,888 | 95,814 | 10,888 | |
| May 10 2019 | REPH | Recro Pharma, Inc. | Berelowitz Michael | Director | Grant | A | 0.00 | 7,955 | 0 | 27,412 | 19.5 K to 27.4 K (+40.89 %) |
| May 10 2019 | REPH | Recro Pharma, Inc. | Ajdler Arnaud | Director | Option Exercise | A | 8.80 | 10,888 | 95,814 | 10,888 | |
| May 10 2019 | REPH | Recro Pharma, Inc. | Ajdler Arnaud | Director | Grant | A | 0.00 | 7,955 | 0 | 7,955 | 0 to 8 K |